Showing results (261-270 of 389) with videos related to

Sort By:
Pageof 39
European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2022
Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningiomaNoémie S Minczeles, Eelke M Bos, Reinoud C de Leeuw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 1997
Risk factors for meningitis after transsphenoidal surgeryM O van Aken, S de Marie, A J van der Lely, et al.
Endocrine-Related Cancer|April 20, 2026
Unravelling Mesenteric Fibrosis in Small Intestinal Neuroendocrine Tumours and Implications for Clinical ManagementMaria Castanho Martins, Eva van der Slik, Johannes Hofland, et al.
Annals of the New York Academy of Sciences|November 15, 2006
Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experienceE Korpershoek, F H Van Nederveen, H Dannenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2009
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotateFlavio Forrer, Eric P Krenning, Peter P Kooij, et al.
Clinical Endocrinology|August 3, 2005
The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patientsJoost van der Hoek, Aart-Jan van der Lelij, Richard A Feelders, et al.
Endoscopy International Open|July 18, 2022
Epidemiological, clinical and endoscopic characteristics of colorectal neuroendocrine neoplasms: a population-based study in the NetherlandsAnkie Reumkens, Prapto Sastrowijoto, Heike I Grabsch, et al.
The Journal of Clinical Endocrinology and Metabolism|September 8, 2016
Inhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT GeneS G Creemers, P M van Koetsveld, E S R van den Dungen, et al.
Drugs|December 19, 2018
Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future PerspectivesAura D Herrera-Martínez, Johannes Hofland, Leo J Hofland, et al.
The Journal of Clinical Endocrinology and Metabolism|July 24, 2008
Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomantS J C M M Neggers, M O van Aken, W W de Herder, et al.
Pageof 39